Reversibly-crosslinked poly(vinyl alcohol)-b-poly(N-vinylcaprolactam) PVOH-b-PNVCL nanogels were prepared by using a redox-responsive crosslinking agent, 3,3'-dithiodipropionic acid (DPA), to crosslink the PVOH corona, above the lower critical solution temperature (LCST) of the PNVCL block. Stability of the as-prepared cross-linked nanogels against heating and dilution with water was studied by dynamic 10 light scattering (DLS) to follow the evolution of the hydrodynamic diameter and size distribution. Stability under reductive condition was also studied with DLS and transmission electron microscopy (TEM) after exposure to dithiothreitol (DTT) buffer solutions at different pH. Reversibility of the crosslinking was conducted by treating the de-crosslinked nanogels with hydrogen peroxide (H2O2) above the LCST. As a hydrophobic drug model, Nile red (NR) was loaded into the crosslinked nanogels, and 15 triggered release behaviours were studied after exposure to the same DTT buffer solutions. Moreover, two PVOH-b-PNVCL copolymers with different compositions and LCST were used to evaluate the effect of LCST on the release behaviours of the crosslinked nanogels. Cytotoxicity of the crosslinked nanogels against mouse fibroblast-like L929 cell line was assessed via the MTS assay, and preliminary studies on cellular uptake of the crosslinked nanogels within human melanoma MEL-5 cells was also carried out 20 with fluorescence microscopy and fluorescence-activated cell sorting.
Introduction
Recently, considerable efforts were devoted to the development of novel drug delivery systems (DDS), which are expected to overcome the key therapeutical 25 issues emerging in current clinical practices, such as poor intracellular delivery, lack of control over the release behaviours, significant side effects, etc. 1, 2 In the past few years, nano-sized polymer micelles have been suggested as promising vehicles for DDS due to 30 their outstanding advantages in drug loading capacity and cellular uptake efficiency, as well as their nanoscaled dimension which can accomplish an enhanced permeability and retention (EPR) effect in tumour sites. [2] [3] [4] [5] Generally, self-assembled micelles could be 35 obtained from unimers above the critical micelle concentration (CMC); and when stimuli-responsive materials are used, release of the drug payloads could be triggered by external stimuli, such as light or magnetic field application, reductive agents activation, 40 variation in pH, temperature or ionic strength, etc. [4] [5] [6] [7] However, the main drawback of these physicallyassembled micelles should be the incapacity to avoid premature release during the in vivo delivery routine. 2, 8 To circumvent this limitation, crosslinking strategies 45 have been attempted. The covalently stabilized micelles, particularly shell crosslinked micelles, are attracting increasing attention. 9 Various chemical reactions were attempted to crosslink the shell of those physically-assembled micelles, such as carbodiimide 50 coupling of carboxylic acid groups with diamines, 10 coupling of hydroxyl groups with divinyl sulfone, 11 UV-induced coupling of cinnamoyl groups, 12 to cite only a few.
These traditional covalently-crosslinked structures 55 aimed for DDS application are always limited by a number of drawbacks, including poor solubility, low reactivity, toxicity and lack of control over the release behaviours due to the irreversible crosslinking structures, etc. 4, 6, 13 An alternative approach involves 60 the reversible crosslinking with disulfide bonds, which are redox-responsive and can be easily cleaved when exposed to some reductive reagents, such as dithiothreitol (DTT) or glutathione. It was reported that concentration of glutathione in the cytosol (10 release. 13, [16] [17] [18] [19] [20] [21] [22] [23] [24] . As far as we know, poly(N-vinylcaprolactam) (PNVCL) is one of the most recently studied thermoresponsive macromolecules with lower critical solution temperature (LCST) of ca. 32°C. And change 5 in temperature can cause the phase transition between hydrophobic and hydrophilic state. 5 When involved in a block copolymer with another hydrophilic block, it results in the formation or dissociation of core/coronastructured micelles, driven by the change in 10 temperatures. [3] [4] [5] On the other side, poly(vinyl alcohol) (PVOH)-based micelles or hydrogels have also been extensively investigated as good candidates for DDS application, due to the hydrophilic essence and also excellent biocompatibility of PVOH block. 25 -28 15 Recently, we have reported the synthesis of welldefined PVOH-b-PNVCL copolymers with different compositions via the cobalt-mediated radical polymerization (CMRP) strategy, 27, 29, 30 and dependence of LCST on chemical composition of the 20 copolymers was also properly investigated. 30 Up to now, thermo-induced micelles from poly(Nisopropylacrylamide) PNIPAm or PNVCL-based amphiphilic copolymers, with a hydrophobic PNIPAm or PNVCL core and another hydrophilic block as 25 corona above the LCST, have ever been widely reported. 18, [31] [32] [33] [34] In the case of PVOH-b-PNVCL copolymers, thermo-induced formation of micelles with PVOH corona was reported in our recent report. 30 However, due to their inferior stability against heating, 30 inter-particles agglomeration occurred upon further heating above the LCST.
In this work, we report the synthesis and loading/release properties of the reversiblycrosslinked thermo-and redox-responsive nanogels 35 based on PVOH-b-PNVCL copolymers (Scheme 1). 3,3'-dithiodipropionic acid (DPA) was used to crosslink the PVOH corona above the LCST of the PNVCL blocks; then crosslinked nanogels were obtained after cooling down below the volume phase 40 transition temperature (VPTT) of the crosslinked structures. Stability of the corsslinked nanogels against heating and diluting with de-ionized water was evaluated with dynamic light scattering (DLS) technique. Stability of the crosslinked nanogels against 45 reductive reagents was also studied with DLS after exposing to DTT buffer solution (10 mM) with different pH values, while an oxidizing agent (H 2 O 2 ) was used to evaluate the reversibility of the crosslinking. Nile red (NR) was used as a hydrophobic 50 drug model to study the triggered release behaviours under different conditions. Cytotoxicity of the crosslinked nanogels against the mouse fibroblast-like L929 cells was also evaluated via the MTS assay, and preliminary studies on cellular uptake of the 55 crosslinked nanogels within human melanoma MEL-5 cells were finally investigated. 30 The physico-chemical features of the PVOH-b-PNVCL copolymers used in this work 85 were summarized in Table 1 .
Methods

Preparation of PVOH-b-PNVCL crosslinked nanogels
PVOH-b-PNVCL shell crosslinked micelles were firstly prepared from the aqueous polymer solution 90 above its LCST, and after the crosslinking reaction, the crosslinked nanogels were obtained upon cooling down below the VPTT of the crosslinked structures. Typically, the PVOH 180 -b-PNVCL 110 copolymer was dissolved in 20 mL of de-ionized water to obtain a 95 polymer concentration of 0.05 wt.% (i.e. 7.8 × 10 -5 mol VOH monomer units) before stirring and heating to 50°C. Immediately, milky-white colloidal aggregates were detected upon heating, indicating the formation of thermo-induced micelles. After equilibration at 100 50°C for 10 min, DPA (8.4 mg, 3.9×10 -5 mol, molar ratio DPA/VOH = 1:2), EDC (12.0 mg, 7.8×10 -5 mol) and DMAP (11.4 mg, 9.5×10 -5 mol) were added. After degassing by bubbling nitrogen for 20 min, the mixture was stirred at 50°C for another 48 h. Upon cooling 105 down to room temperature, the mixture was dialyzed (cut-off: 3,500 g/mol) against de-ionized water for another 48 h, in order to remove the free DPA, catalysts and by-products. White powders were obtained after freeze-drying.
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Stability of the PVOH-b-PNVCL crosslinked nanogels and reversibility of the crosslinking Stability of the PVOH-b-PNVCL crosslinked nanogels against swelling was investigated by diluting the crosslinked nanogels solution (0.05 wt.%) with deionized water at 25°C. DLS measurement (25°C) was used to follow the change in hydrodynamic diameters (D h ) and size distribution (PDI) after dilution. For each dilution period, the solution was kept for at least 1 h to 5 reach the swelling equilibrium before characterization.
Stability of the PVOH-b-PNVCL crosslinked nanogels against heating was also studied by DLS with the crosslinked nanogels solution (0.05 wt.%) under gradual heating from 25 to 50°C. 10 Stability of the PVOH-b-PNVCL crosslinked nanogels against reductive reagents was studied by exposing the crosslinked nanogels solution (0.05 wt.%) to 10-mM DTT solution in different degassed buffers, such as PBS (pH 7.4), PBS (pH 8.5) and 15 NaAc/HAc (pH 4.5) buffers at 37°C. At each predetermined interval, 1-mL nanogels solution were collected with a syringe for DLS measurement (25°C), in order to monitor the change in D h and PDI. After 24-h treatment, the mixture was cooled down and dialyzed 20 (cut-off: 3,500 g/mol) against de-ionized water at room temperature for another 48 h. The purified decrosslinked (DCL) nanogels solution was freeze-dried and white powders were obtained.
Reversible crosslinking (RCL) of the PVOH-b- 25 PNVCL DCL nanogels was conducted by adding 1 mL of hydrogen peroxide solution (30 wt.%) into 10 mL of DCL nanogels solution (0.05 wt.%) at 50°C and then stirred overnight. RCL nanogels white powders were obtained after freeze-drying.
30
Model studies of guest loading and triggered release
Nile red, a hydrophobic drug model, was loaded into the PVOH-b-PNVCL crosslinked nanogels in order to monitor the redox-triggered release behaviours with a fluorometer. Herein, after the thermo-induced 35 formation of PVOH-b-PNVCL micelles at 50°C, 2 mL of NR solution in THF (0.2 mg/mL) were added, and then the mixture was stirred for another 30 min in dark, at the end of which the THF solvent was supposed to be fully evaporated. The crosslinking reaction was 40 carried out according to the above-mentioned protocol. The non-encapsulated NR was removed by filtration (0.8 μm), and other free DPA and by-products were removed via dialysis against de-ionized water in dark.
To study the release profiles, 10 mL of the NR- 490 nm was measured by using a Power wave X (Biotek instrument Inc.) micro-plate reader. Percentage cell viabilities were determined relative to the untreated cells (control, 100% viability).
Cellular uptake into human melanoma MEL-5 cells
100
Qualitative studies of the cellular uptake with fluorescence microscopy were carried out with the treated MEL-5 cells after internalizing with NRuploaded PVOH-b-PNVCL crosslinked nanogels. MEL-5 cells (3.8 × 10 5 ) were seeded in a 12-well plate 105 within 2 mL of DMEM complete medium. After 24-h incubation, the culture medium was replaced with 2 mL of fresh DMEM complete medium (blank) or NRloaded crosslinked nanogels in DMEM complete medium (1.0, 0.5, 0.25 or 0.1 mg/mL), respectively.
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After incubating for a predetermined period (3, 6, 15 or 24 h), the medium was removed and the cells were rinsed twice with PBS buffer (Ca 2+ /Mg 2+ free) to remove the free nanogels. Then the cells were treated with paraformaldehyde (4 vol 
Statistical analysis
Cell culture experiments were performed in triplicate. Results were all presented as mean value (± standard deviation). Statistical analyses of the data were performed using the unpaired and two-tailed Student's 30 t-test. Statistical significance was determined at p < 0.05.
Characterization
Raman spectra of the PVOH-b-PNVCL crosslinked nanogels samples and the parent PVOH-b-PNVCL 35 block copolymers after freeze-drying were recorded using a LabRam spectrometer, equipped with an Olympus confocal microscope and a liquid nitrogencooled open-electrode detector (1024 × 256 CCD). An argon-ion laser with emission wavelength at 514.5 nm 40 and power of 100 mW were used. All measurements were integrated within 50 s.
Dynamic light scattering (DLS) measurements were carried out with a Malvern Instrument Nano-ZS, which was equipped with a He-Ne laser (λ = 663 nm) 45 and scattering angle of 90°. The correlation function was analysed via the CONTIN method, and D h was determined by using the Stokes-Einstein equation. The averaged D h was obtained from three different runs. Standard deviation was used to evaluate the size 50 polydispersity index (PDI). Every measurement was carried out with a PVOH-b-PNVCL crosslinked nanogels or the parent PVOH-b-PNVCL polymer solution with a fixed concentration of 0.05 wt.%.
Transmission electron microscopy (TEM) was used 55 to measure the size of the PVOH-b-PNVCL crosslinked nanogels and analyse their morphology with a Philips CM-100 microscope. A drop of the nanogels solution was placed onto a carbon-coated copper grid and left to dry under air before 60 observation. The size distribution and average size was obtained by sampling ca. 100 particles on the TEM images.
Scanning electron microscopy (SEM) was used to study the surface of the PVOH-b-PNVCL crosslinked 65 nanogels with a JSM 840A microscope at 4 kV in high vacuum conditions. A drop of nanogels solution (0.05 wt.%) was deposited on a glass substrate, and dried overnight at RT under air. Then the sample was sputtered with gold in a cathode evaporator under 70 argon atmosphere before observation.
Turbidimetry measurement of the PVOH-b-PNVCL crosslinked nanogels or the parent PVOH-b-PNVCL polymer solutions (0.05 wt.%) was carried out with a Hitachi U-3300 spectrophotometer from 25 to 50°C at 75 a heating rate of 1°C/min. Transmittance at 700 nm was plotted against the temperature, and LCST was defined as the temperature where transmittance started to decrease. 
Results and discussion
Preparation of the crosslinked nanogels
Similarly to PNIPAm, PNVCL homopolymer could also dissolve in cold and dilute aqueous medium; however, it becomes insoluble above ca. 32°C due to 100 its thermo-induced hydrophilic/hydrophobic phase transition around its LCST. 5 The value of this LCST is highly dependent on the concentration and chain length of PNVCL. In the case of copolymers, the nature, content and block length of the second comonomer might also affect the LCST. Generally, the lower the content, the shorter length of the thermoresponsive block, the higher the LCST. [35] [36] [37] In order to 5 tune the LCST of PNVCL block above the human body temperature (37°C), hydrophilic PVOH block was chosen, and block copolymers of PVOH-b-PNVCL were prepared via cobalt-mediated radical polymerization 29, 38 following our previous report.
30 10 Briefly, a poly(vinyl acetate) macroinitiator endcapped with Co(acac) 2 was prepared in the bulk using an alkyl-Co(acac) 2 initiator at 40°C. Then, the polymerization of N-vinylcaprolactam (NVCL) monomers was initiated by this macroinitiator in DMF 15 at 40°C to synthesize PVAc-b-PNVCL copolymers. Methanolysis of the PVAc block in the presence of potassium hydroxide led to the corresponding PVOHb-PNVCL block copolymers.
As reported in our previous work, 30 above the LCST 20 of the PNVCL block, the collapsed hydrophobic PNVCL block formed the core of the thermo-induced micelles, while the PVOH block formed the hydrophilic corona. However, these physically assembled micelles were not stable against heating, 25 and inter-micellar agglomeration was observed when the temperature was further increased above the LCST. Furthermore, dissociation into unimers occurred when temperature was decreased below the LCST. Herein, 3,3-dithiodipropionic acid (DPA; 30 Scheme 1) is used to crosslink the PVOH corona above the LCST. And after cooling down below the VPTT, the PNVCL block becomes hydrophilic, and nanogels are obtained due to the presence of crosslinking. Additionally, the presence of disulfide bonds in the 35 crosslinker also makes it possible to de-crosslink the nanogels with a reducing agent, such as dithiothreitol (DTT). Thus, if some drugs are loaded within the crosslinked nanogels, upon the DTT-treatment below the LCST of PNVCL blocks, the crosslinked nanogels 40 could dissociate into unimers, thereby triggered release is achieved (Scheme 1). However, upon the DTT-treatment above the LCST of PNVCL blocks, the micellar structures would remain intact, and the drugs could be still retained within the micellar structure, 45 even with the crosslinking structures are dissociated. Here, two different PVOH-b-PNVCL copolymers, one with LCST at human body temperature (37°C) and the other above it (41°C), are used (parameters listed in Table. 1), in order to exploit the effect of LCST of the 50 PVOH-b-PNVCL copolymers on the subsequent redox-triggered release behaviours.
After purification of the PVOH-b-PNVCL crosslinked nanogels via dialysis, Raman spectroscopy was used to confirm the crosslinking reaction with the 55 presence of the S-S stretching vibration at 514 cm -1 , which is typical for the disulfide bonds in the crosslinker (Fig. 1) . Morphology of the crosslinked nanogels was studied with TEM, and approximately spherical crosslinked nanogels were observed, within 60 the size range of 45 ~ 95 and 70 ~ 110 nm for AM01 (Fig. 2a) and AM02 (Fig. 2b) detected below the VPTT in the nanogels solution, but none for the polymer solution. Upon further heating, thermo-induced micelles could be detected above 39°C for the polymer solution. However, unlike the polymer solution, neither inter-micellar aggregation 50 nor increase in D h , but slight decrease in D h was observed for the crosslinked nanogels when temperature increased further, indicating a superior resistance of the crosslinked nanogels to inter-particles agglomeration above the VPTT after crosslinking. It is important to note that the average sizes for the 10 non-crosslinked and crosslinked nanogels (AM01) at 50°C were found to be similar: 240 nm (PDI = 0.04 ) against 250 nm (PDI = 0.06)) in the size distribution diagrams in Fig. 4 . The same observation was made on the scattering intensities, which are proportional to the 15 concentration of crosslinked nanogels. Moreover, for the crosslinked nanogels, after cooling down to 25°C from the shell crosslinked micelles (240 nm) at 50°C, the size distribution diagram slightly shifted to the right (290 nm), due to the phase transition and re-20 arrangement of PNVCL block below the VPTT. The presence of nanogels below LCST of the PNVCL blocks could evidence a robust crosslinking within the as-prepared nanogels, compared with unimers obtained from the polymer solution upon cooling from 25 50 to 25°C. On the other side, for an idealist nanogelsbased vehicles targeted for DDS application, it is indispensable to possess a short-term stability but also a long-term stability, and a slight change in size distribution diagram was observed after 3-month analysis: non-crosslinked nanogels (polymer solution) at 50°C, crosslinked (CL) nanogels at 25 and 50°C, de-crosslinked (DCL) nanogels at 25°C, and re-crosslinked (RCL) nanogels at 25°C. The solid lines just serve as eye guidance. 40 It is of great importance for drug vehicles to remain stable during the delivery so that they can efficiently trap the drug payloads until they arrive to the desirable sites. Studies on the stability of crosslinked micelles or nanogels against different solvents were previously 45 reported to evaluate their stability as DDS. 19, [39] [40] [41] Herein, the stability of the crosslinked nanogels AM01 against diluting was studied by following the change in D h when diluted with de-ionized water below the VPTT; while studies on the swelling process were 50 conducted by mixing equal volume of the crosslinked nanogels aqueous solution (0.05 wt.%) and de-ionized water. Change in D h and PDI was measured by DLS and plotted against the swelling period (Fig. 5a ). Similar to other crosslinked systems, 39, 40 slight and 55 lagged swelling was observed against water dilution, indicating a good stability against swelling due to the presence of crosslinking. Additionally, the effect of dilution times on the swelling behaviour of AM01 was also investigated with the size distribution diagrams 60 recorded in Fig. 5b . For each dilution time, the mixture was kept for another one hour to ensure the swelling equilibrium was reached. Slight right-shift of the size distribution patterns was observed with an increase in average size from 290 to 360 nm (1/4 vol. dilution), 65 indicating the crosslinked nanogels experienced a relative mild swelling. Moreover, the size distribution becomes broader, and the swelling was restrained upon further dilution. All these results indicate a neither compact nor rigid crosslinking is accomplished 70 for the as-prepared nanogels; and this slight swelling against dilution is critical to the success of zero premature drug release upon intravenous injection, as compared to those of non-crosslinked micelle systems. As far as we know, the disulfide bonds could be easily dissociated upon exposure to some reductive reagents, 10 such as glutathione or dithiothreitol (DTT) under a mild basic condition, through the well-established thiol-disulfide exchange reaction. 4, 6 Although the concentration of glutathione, which is naturally present in the cytoplasm, is very low (mM-scale), it is 15 still high enough to cleave the disulfide bonds.
Stability of the nanogels and reversibility of the crosslinking
17, 42 As previously reported, the most favourable reductive environment for DTT is under basic conditions. 43 Herein, the stabilities of the crosslinked nanogels AM01 against different DTT (10 mM) buffer solutions 20 at pH values of 7.4 (serum condition), 8.5 (pancreatic condition) and 4.5 (lysosome condition) were also studied by DLS and summarized in Fig. 6a . As expected, the amount of nanogels (qualitatively probed by the intensity of the scattered light) decreased much 25 more rapidly at pH of 8.5 than acidic conditions. In contrast, in the absence of DTT, nanogels remained stable over the experiment period (See ESI, Fig. S4a and S4b †). Fig 4) while scattering intensity decreased from 5.2 to 0.5 after 24-h DTT treatment. Very few nanogels might be left after the 35 DTT-treatment, which may be explained by that disulfide bonds were not completely cleaved and/or the re-oxidation of some thiol groups into disulfide bonds occurred during the sampling or dialysis process. Furthermore, similar to the report of 40 Kataoka, 17,44 due to the non-uniform cleavage of disulfide bonds, the crosslinked nanogels might experience a dramatic swelling, and here an increase in PDI was also observed from 0.2 to 0.8, which was also evidenced in the size distribution diagram in Fig.   45 4. Moreover, presence of the peak in the range of 1 ~ 2 nm for DCL nanogels at 25°C could be ascribed to the free unimers after de-crosslinking. The dissociation of the crosslinked nanogels was also confirmed by the TEM image of DCL nanogels 50 samples after 24-h DTT treatment. In fact, it took us a long time to find nanogels particles on the TEM grid, and a particle with large size of ca. 500 nm was presented in ESI, Additionally, it is of interest to note that DCL nanogels containing thiol groups still retain the thermo-responsive character. As shown in Fig. 4 , upon 10 heating, thermo-induced micelles were observed again within the DCL nanogels solution (0.05 wt.%) at 50°C, and a slightly larger D h (280 nm, PDI 0.11) was observed, compared with that for the physicallyassembled micelles (non-CL nanogels, 240 nm, PDI 15 0.05). This difference might be attributed to the presence of thiol side-groups along the PVOH block after DTT-treatment, which is expected to affect the macromolecular chain hydrophilicity and configuration of the PVOH block, according to a 20 previous report. 45 Moreover, thiol groups were reported to be easily oxidized into disulfide bonds by some oxidative reagents, such as Fe 3+ , hydrogen peroxide, oxygen, etc. 46, 47 Herein, the reversibility of the crosslinking was also tested by adding H 2 O 2 25 solution (30 wt.%) into the solution of DCL nanogels at 50°C (0.05 wt.%). Nanogels particles were detected again by DLS analysis with average D h of 380 nm (PDI 0.28) at 25°C (Fig. 4) , a little bit larger than the former crosslinked nanogels (D h 280 nm, PDI 0.17), which 30 might be attributed to the lower crosslinking degree upon re-crosslinking, thereby higher swelling after cooling down below the VPTT. Furthermore, TEM image (See ESI, Fig. S5d †) and Raman spectra (Fig. 1 , S-S bonds) also evidenced the formation of re-35 crosslinked (RCL) nanogels, suggesting reversibility of the crosslinking.
Model studies on guest loading of Nile red and triggered release behaviours
The reversibly crosslinked nanostructures could 40 impart the those micelles or nanogels with great potential as DDS, since they are capable of effectively trapping the drug payloads within the microenvironment, while triggered release could be accomplished by the external stimuli. 7, 8, 36 To explore 45 the potential of PVOH-b-PNVCL reversiblycrosslinked nanogels as DDS, Nile red, a hydrophobic dye, was chosen as a model drug and loaded into the hydrophobic PNVCL domain above the LCST (Scheme 1). It has been reported that fluorescence 50 emission of NR is negligible in aqueous solution due to its weak solubility (< 1 μg/mL, 25°C); however, it increases substantially in a hydrophobic environment. 41 Stable nanogels aqueous dispersion with red luminance was obtained after the loading of 55 NR (See ESI, Fig. S6b †) , while transparent solution without NR loaded was observed for crosslinked nanogels solution (See ESI, Fig. S6a †) . Spherical nanogels were observed again from the TEM image of the NR-loaded crosslinked nanogels AM01 (See ESI, 60 Fig. S6c †) , and a slight increase in D h was observed from 290 to 300 nm for NR-loaded AM01, due to the presence of NR (See ESI, Fig. S7 †) . The drug loading capacity (mass ratio of NR loaded to nanogels) was spectrophotometrically estimated to be ca. 1.9 wt.% 65 and drug loading efficiency (mass ratio of NR loaded to NR fed) of 48%, comparable to the loading capability of another disulfide-crosslinked nanogels as DDS, as reported by Du and Li. respectively. After removing the precipitated NR, the supernatant solution was checked with a fluorometer, and fluorescence emission intensity at 595 nm (Ex: 485 nm) was 237, 251 and 266, respectively, while for the NR-loaded crosslinked nanogels AM01, the 95 fluorescence intensity was higher than 25,000. This confirmed that the solubility of NR in water was not affected by pH, in agreement with the previous report. 42 This time-dependent release behaviour strongly supports that the drug release was indeed dissociation of the nanogels and unavoidable oxidation of thiol groups to disulfide bonds by ambient O 2 , as some nanogels could still be detected in Fig. 4 To elucidate the effect of the composition as well 5 as LCST of the PVOH-b-PNVCL copolymers on the release behaviours, NR was also attempted to be loaded within the nanogels AM02, which were prepared from PVOH 226 -b-PNVCL 494 copolymer with LCST of 37°C. A higher loading capacity (2.5 wt.%) 10 and efficiency (62 %) of NR were obtained above the LCST, due to the larger hydrophobic PNVCL domains, as well as larger size (D h of 460 nm). The release behaviours were also followed in the presence or not of DTT (10 mM, pH 8.5). As shown in Fig. 7b , 15 similarly to the release behaviours of AM01, very small amount of NR was released in the absence of DTT. However, as expected, the release was accelerated when exposed to DTT. It should be noted that this release was very low (36%) after 24-h DTT 20 treatment, compared to 80% for AM01 in Fig. 7a under the same condition. To explain the difference between these two release profiles, DLS was used to check the size distribution of the NR-loaded crosslinked nanogels solutions at 37°C after 24-h DTT treatment, for the nanogels with LCST below or near 37°C, the remaining NR was still trapped within the nanogels, resulting in a retarded release even after the decrosslinking (Scheme 1). five independent samples, comparing to the value ca. 0.554 for those untreated cells. Thus, it justifies that the use of MTS assay to evaluate the PVOH-b-PNVCL nanogels was feasible and presence of PVOH-b-PNVCL nanogels will not disturb the absorbance of 80 the final formazan product. The cells were treated with crosslinked nanogels AM01 and AM02 with different incubation concentrations for different periods, while non-treated cells were taken as a control (100% viability). As shown in Fig. 8a and 8b, both two 85 nanogels exhibit high cell viability over 85%, even after 48-h incubation even with concentrated nanogels solution (2 mg/mL). The slight effect on the cell viability and cell proliferation capability might suggest low cytotoxicity for these crosslinked nanogels, as 90 well as the crosslinking nanostructures. Generally, the enhanced efficiency of disease treatment could be achieved via higher drug release 10 efficiency and/or efficient uptake of the drug-loaded DDS. Here, the cellular uptake of the NR-loaded crosslinked nanogels AM01 into the human melanoma MEL-5 cells could be directly visualized by fluorescence microscopy (Fig. 9a) , with NR as a Fig. S9 †) . Fluorescence-activated cell sorting (FACS) technique was also used to characterize the treated MEL-5 cells, while un-treated cells were taken as blank. It is obvious to see two 25 totally different cell populations in Fig. 9b-1 and Fig.  9b-2 , with a big shift in the histograms in Fig. 9b-3 , and also sharp increase in fluorescence intensity, as listed in Fig. 9b-4 . These FACS results also corroborate the cellular uptake of the crosslinked 30 nanogels, which is a prerequisite for the intracellular DDS. Furthermore, quantitative studies on the cellular uptake were carried out with the FACS results. Mean fluorescence intensity (MFI), which was denoted as the ratio of fluorescence intensity per 10,000 treated 35 cells to that of 10,000 un-treated cells, was used as an indirect measure to evaluate the cellular uptake efficiency. This approach has also been used to assess the uptake of some drugs 50 and gene delivery vehicles, 51 etc. Here, MFI was plotted against the 40 incubation period as well as incubation concentration in Fig. 9c-1 and Fig. 9c-2 , respectively. As shown, a faster increase in MFI was observed within the first 15 h, while a slight increase afterward. A dose-dependent cellular uptake was also detected when the incubation 45 concentration of crosslinked nanogels was increased, suggesting the possibility of manipulation of cellular uptake efficiency of the PVOH-b-PNVCL crosslinked nanogels via control over the incubation concentration or/and incubation period. 
Conclusions
10
In this study, reversibly-crosslinked thermo-and redox-responsive PVOH-b-PNVCL nanogels were fabricated with disulfide-bearing crosslinking reagent 3,3'-dithiodipropionic acid. Their spherical shape was confirmed by TEM, with Dh of ca. 280 nm (PDI 0.17). 15 Good colloidal stability against heating was confirmed above the VPTT, with a slight shrinkage rather than inter-particles agglomeration. Compared to noncrosslinked micelles, only a slight swelling of the crosslinked nanogels was observed against water 20 dilution below the VPTT, which is critical to the success of zero premature drug release upon intravenous injection. However, the crosslinked nanogels can be easily dissociated in a reductive environment thanks to the redox-sensitive crosslinking 25 structures, so that the drug release could be triggered intracellularly. Interestingly, the de-crosslinked copolymers (bearing free thiols along the PVOH block) can be crosslinked again by exposure to oxidative agent, such as H2O2, above the LCST. 30 Hydrophobic model drug (NR) could be easily loaded into the crosslinked nanogels, while cleavage of the disulfide bonds can effectively trigger the drug release (80% drug release in presence of 10-mM DTT while only 8% without DTT in 24 h). This specific redox- 35 responsive property might also facilitate the release of the loaded drugs within the cytoplasm in response to glutathione (10 mM). In addition, we also disclosed that the use of PVOH-b-PNVCL copolymer exhibiting a LCST above 37°C was preferable, with a fast release 40 upon exposure to DTT-treatment under physiological condition. Cytotoxicity studies disclosed a low toxicity and good biocompatibility with mouse fibroblast-like L929 cell line for the crosslinked nanogels. Moreover, the crosslinked nanogels can 45 easily internalize within the human melanoma MEL-5 cells. Incubation concentration-and period-dependent cellular uptake was also detected for these PVOH-b-PNVCL crossliniked nanogels. This kind of crosslinked nanogels is thus promising for the 50 triggered delivery of hydrophobic drugs for intracellular release.
